Skip to main content

Animations

MJFF Publications

3001 - 3010 of 9104 Results
Title
Year
  • Year
  • 2016
  • 2022
  • 2013
  • 2026
  • 2016
  • 2022
  • 2014
  • 2013
  • 2017
  • 2017
  • Summary Details
    OPEN
    Title: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?
    Journal Name: Hippocampus
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hipo.22671
    Citation Count: 181
  • Summary Details
    OPEN
    Title: Feedforward activation of PRKN/parkin
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615
    Citation Count: 9
  • Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH‐SY5Y cells
    2013
    Summary Details
    RESTRICTED
    Title: Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH‐SY5Y cells
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.12497
    Citation Count: 40
  • Summary Details
    OPEN
    Title: DAT-SPECT-based subtype and stage inference in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-026-01347-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neuroimmunology of the Interleukins 13 and 4
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci6020018
    Citation Count: 126
  • Summary Details
    OPEN
    Title: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?
    Journal Name: Future Neurology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/fnl.13.14
    Citation Count: 54
  • Serum lipid alterations in GBA-associated Parkinson's disease
    2017
    Summary Details
    RESTRICTED
    Title: Serum lipid alterations in GBA-associated Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026
    Citation Count: 90
  • Summary Details
    OPEN
    Title: Parkinson's disease prevalence in Fabry disease: A survey study
    Journal Name: Molecular Genetics and Metabolism Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.